SEARCH

SEARCH BY CITATION

References

  • Aid S. and Bosetti F. (2011) Targeting cyclooxygenases-1 and -2 in neuroinflammation: therapeutic implications. Biochimie 93, 4651.
  • Akbar M., Calderon F., Wen Z. and Kim H. Y. (2005) Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival. Proc. Natl Acad. Sci. USA 102, 1085810863.
  • Appleton K. M., Rogers P. J. and Ness A. R. (2010) Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am. J. Clin. Nutr. 91, 757770.
  • Balanza-Martinez V., Fries G. R., Colpo G. D., Silveira P. P., Portella A. K., Tabares-Seisdedos R. and Kapczinski F. (2011) Therapeutic use of omega-3 fatty acids in bipolar disorder. Expert Rev. Neurother. 11, 10291047.
  • Basselin M., Ramadan E., Chen M. and Rapoport S. I. (2011) Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. Neurochem. Res. 36, 139145.
  • Calder P. C. (2009) Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie 91, 791795.
  • Calon F. (2011) Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers. Curr. Alzheimer Res. 8, 470478.
  • Canadian Council on Animal Care (1993) Guide to the Care and use of Experimental Animals. Canadian Council on Animal Care, Ottawa.
  • Chen C. T., Liu Z. and Bazinet R. P. (2011) Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J. Neurochem. 116, 363373.
  • Choi S. H. and Bosetti F. (2009) Cyclooxygenase-1 null mice show reduced neuroinflammation in response to beta-amyloid. Aging (Albany NY) 1, 234244.
  • Choi S. H., Langenbach R. and Bosetti F. (2008) Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. FASEB J. 22, 14911501.
  • Cole G. M., Ma Q. L. and Frautschy S. A. (2010) Dietary fatty acids and the aging brain. Nutr. Rev. 68(Suppl 2), S102S111.
  • Crawford M. A., Leigh Broadhurst C., Guest M., Nagar A., Wang Y., Ghebremeskel K. and Schmidt W. F. (2013) A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution. Prostaglandins Leukot. Essent. Fatty Acids 88, 513.
  • DeMar J. C. Jr, Ma K., Bell J. M. and Rapoport S. I. (2004) Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91, 11251137.
  • Duffield J. S., Hong S., Vaidya V. S., Lu Y., Fredman G., Serhan C. N. and Bonventre J. V. (2006) Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177, 59025911.
  • Folch J., Lees M. and Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497509.
  • Golovko M. Y. and Murphy E. J. (2006) Uptake and metabolism of plasma-derived erucic acid by rat brain. J. Lipid Res. 47, 12891297.
  • Golovko M. Y. and Murphy E. J. (2008) An improved LC-MS/MS procedure for brain prostanoid analysis using brain fixation with head-focused microwave irradiation and liquid-liquid extraction. J. Lipid Res. 49, 893902.
  • Golovko M. Y., Barcelo-Coblijn G., Castagnet P. I., Austin S., Combs C. K. and Murphy E. J. (2009) The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response. Mol. Cell. Biochem. 326, 5566.
  • He C., Qu X., Cui L., Wang J. and Kang J. X. (2009) Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid. Proc. Natl Acad. Sci. USA 106, 1137011375.
  • Hoffman D. R., Boettcher J. A. and Diersen-Schade D. A. (2009) Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot. Essent. Fatty Acids 81, 151158.
  • Hong S., Gronert K., Devchand P. R., Moussignac R. L. and Serhan C. N. (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 278, 1467714687.
  • Hong S., Lu Y., Yang R., Gotlinger K. H., Petasis N. A. and Serhan C. N. (2007) Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J. Am. Soc. Mass Spectrom. 18, 128144.
  • Huang W. L., King V. R., Curran O. E., Dyall S. C., Ward R. E., Lal N., Priestley J. V. and Michael-Titus A. T. (2007) A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. Brain 130, 30043019.
  • Huang L., Wang C. F., Serhan C. N. and Strichartz G. (2011) Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 152, 557565.
  • Kang J. X., Wang J., Wu L. and Kang Z. B. (2004) Transgenic mice: fat-1 mice convert n-6 to n-3 fatty acids. Nature 427, 504.
  • Kasuga K., Yang R., Porter T. F., Agrawal N., Petasis N. A., Irimia D., Toner M. and Serhan C. N. (2008) Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J. Immunol. 181, 86778687.
  • Kim H. W., Rapoport S. I. and Rao J. S. (2011a) Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol. Psychiatry 16, 419428.
  • Kim H. Y., Moon H. S., Cao D., Lee J., Kevala K., Jun S. B., Lovinger D. M., Akbar M. and Huang B. X. (2011b) N-Docosahexaenoylethanolamide promotes development of hippocampal neurons. Biochem. J. 435, 327336.
  • Lafourcade M., Larrieu T., Mato S. et al. (2011) Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat. Neurosci. 14, 345350.
  • Lalancette-Hebert M., Julien C., Cordeau P., Bohacek I., Weng Y. C., Calon F. and Kriz J. (2011) Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage. Stroke 42, 29032909.
  • Lukiw W. J., Cui J. G., Marcheselli V. L., Bodker M., Botkjaer A., Gotlinger K., Serhan C. N. and Bazan N. G. (2005) A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Investig. 115, 27742783.
  • Marcheselli V. L., Hong S., Lukiw W. J. et al. (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 4380743817.
  • Mingam R., Moranis A., Bluthe R. M., De Smedt-Peyrusse V., Kelley K. W., Guesnet P., Lavialle M., Dantzer R. and Laye S. (2008) Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur. J. Neurosci. 28, 18771886.
  • Mukherjee P. K., Marcheselli V. L., Serhan C. N. and Bazan N. G. (2004) Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl Acad. Sci. USA 101, 84918496.
  • Murphy E. J. (2010) Brain fixation for analysis of brain lipid-mediators of signal transduction and brain eicosanoids requires head-focused microwave irradiation: an historical perspective. Prostaglandins Other Lipid Mediat. 91, 6367.
  • Orr S. K., Tong J. Y., Kang J. X., Ma D. W. and Bazinet R. P. (2010) The fat-1 mouse has brain docosahexaenoic acid levels achievable through fish oil feeding. Neurochem. Res. 35, 811819.
  • Orr S. K., Trepanier M. O. and Bazinet R. P. (2013) n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. Prostaglandins Leukot. Essent. Fatty Acids 88, 97103.
  • Rao J. S., Ertley R. N., DeMar J. C. Jr, Rapoport S. I., Bazinet R. P. and Lee H. J. (2007a) Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 12, 151157.
  • Rao J. S., Ertley R. N., Lee H. J., DeMar J. C. Jr, Arnold J. T., Rapoport S. I. and Bazinet R. P. (2007b) n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol. Psychiatry 12, 3646.
  • Rosenberger T. A., Villacreses N. E., Hovda J. T., Bosetti F., Weerasinghe G., Wine R. N., Harry G. J. and Rapoport S. I. (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88, 11681178.
  • Rudaya A. Y., Steiner A. A., Robbins J. R., Dragic A. S. and Romanovsky A. A. (2005) Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R1244R1252.
  • Serhan C. N. and Petasis N. A. (2011) Resolvins and protectins in inflammation resolution. Chem. Rev. 111, 59225943.
  • Serhan C. N., Hong S., Gronert K., Colgan S. P., Devchand P. R., Mirick G. and Moussignac R. L. (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196, 10251037.
  • Serhan C. N., Chiang N. and Van Dyke T. E. (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349361.
  • Serhan C. N., Yang R., Martinod K., Kasuga K., Pillai P. S., Porter T. F., Oh S. F. and Spite M. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 206, 1523.
  • Serhan C. N., Dalli J., Karamnov S., Choi A., Park C. K., Xu Z. Z., Ji R. R., Zhu M. and Petasis N. A. (2012) Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 26, 17551765.
  • Sheets K. G., Zhou Y., Ertel M. K., Knott E. J., Regan C. E. Jr, Elison J. R., Gordon W. C., Gjorstrup P. and Bazan N. G. (2010) Neuroprotectin D1 attenuates laser-induced choroidal neovascularization in mouse. Mol. Vis. 16, 320329.
  • Smith B. K., Holloway G. P., Reza-Lopez S., Jeram S. M., Kang J. X. and Ma D. W. (2010) A decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance. Appl. Physiol. Nutr. Metab. 35, 699706.
  • Spite M., Norling L. V., Summers L., Yang R., Cooper D., Petasis N. A., Flower R. J., Perretti M. and Serhan C. N. (2009a) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 12871291.
  • Spite M., Summers L., Porter T. F., Srivastava S., Bhatnagar A. and Serhan C. N. (2009b) Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br. J. Pharmacol. 158, 10621073.
  • Sun Y. P., Oh S. F., Uddin J., Yang R., Gotlinger K., Campbell E., Colgan S. P., Petasis N. A. and Serhan C. N. (2007) Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 93239334.
  • Xu Z. Z., Zhang L., Liu T., Park J. Y., Berta T., Yang R., Serhan C. N. and Ji R. R. (2010) Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med. 16, 592597; 591p following 597.
  • Yang R., Chiang N., Oh S. F. and Serhan C. N. (2011) Metabolomics-lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr. Protoc. Immunol. Nov; Chapter 14, Unit 14.26.
  • Yong V. W. and Rivest S. (2009) Taking advantage of the systemic immune system to cure brain diseases. Neuron 64, 5560.
  • Zhao Y., Calon F., Julien C., Winkler J. W., Petasis N. A., Lukiw W. J. and Bazan N. G. (2011) Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models. PLoS ONE 6, e15816.